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ABSTRACT
Rotator cuff tendon tear is one of themost common causes of chronic shoulder pain and disability. In
this study, we investigated the therapeutic effects of ultrasound-guided human umbilical cord blood
(UCB)-derived mesenchymal stem cell (MSC) injection to regenerate a full-thickness subscapularis
tendon tear in a rabbitmodel by evaluating the grossmorphologyandhistologyof the injected tendon
and motion analysis of the rabbit’s activity. At 4 weeks after ultrasound-guided UCB-derived MSC
injection, 7 of the 10 full-thickness subscapularis tendon tears were only partial-thickness tears,
and3 remained full-thickness tendon tears. The tendon tear size andwalking capacity at 4weeks after
UCB-derived MSC injection under ultrasound guidance were significantly improved compared with
the same parameters immediately after tendon tear. UCB-derived MSC injection under ultrasound
guidance without surgical repair or bioscaffold resulted in the partial healing of full-thickness rotator
cuff tendon tears in a rabbit model. Histology revealed that UCB-derivedMSCs induced regeneration
of rotator cuff tendon tear and that the regenerated tissue was predominantly composed of type I
collagens. In this study, ultrasound-guided injection of human UCB-derived MSCs contributed to re-
generation of the full-thickness rotator cuff tendon tear without surgical repair. The results demon-
strate the effectiveness of local injection of MSCs into the rotator cuff tendon. STEM CELLS
TRANSLATIONAL MEDICINE 2015;4:1344–1351
SIGNIFICANCE
The results of this study suggest that ultrasound-guided umbilical cord blood-derived mesenchymal
stem cell injection may be a useful conservative treatment for full-thickness rotator cuff tendon tear
repair.
INTRODUCTION
Rotator cuff tendon tear is one of the most com-
mon causes of chronic shoulder pain and disabil-
ity. The incidence of the full-thickness rotator
cuff tendon tear ranges from 5% to 40% [1].
Chronic tendon degeneration is currently con-
sidered the primary contributing factor in the
pathogenesis of rotator cuff tendon tear [2].
Treatment for rotator cuff tendon tear is divided
into conservative therapy (exercise, electrother-
apy, acupuncture, manual therapy, taping, and
steroid andplatelet-rich plasma [PRP] injections)
and surgery [3]. The surgical repair of a tendon
tear is one of the most common orthopedic pro-
cedures [4]. However, the failure rates for rota-
tor cuff tendon repair ranged from 20% to 90%
[5] and success of the procedure depends on
the patient’s age, tear size, chronicity, muscle at-
rophy and fatty degeneration, tendon quality,
operative technique, and postoperative rehabil-
itation treatment [6]. Revision rotator cuff sur-
gery has been shown to have a less successful
outcome than primary repair [7].
Since current therapeutic approaches do not
lead to physiological restoration of the rotator
cuff tendon tear and the quality at the distal
end of the rotator cuff tendon tear is suboptimal
[8], a new biological treatment strategy is needed
to regenerate the torn tendon and reduce scar
formation. The new treatment should create an
optimized environment for the restoration of
the torn tendon. Mesenchymal stem cells (MSCs)
have been shown to differentiate into various cell
types, such as chondrocytes, neural cells, and en-
dothelial cells, both in vivo and in vitro [9–13], and
they are extracted from various sources, includ-
ing bone marrow, adipose tissue, and umbilical
cord blood (UCB). UCB is a promising source of
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humanMSCs because of its easy availability, high proliferation ca-
pacity, and low immunogenicity [10, 13, 14].
A previous study showed that surgically implanting tissue-
engineered MSC-collagen composites significantly improves the
biomechanical properties of tendon repair tissues in full thick-
ness, full length, central defects created in the patellar tendons
of the animals providing the cells [15]. In cases of the rotator cuff
tear, it has been shown that repairing a full-thickness infraspina-
tus tendon tear using a bioabsorbable material with bone
marrow-derived MSCs can regenerate tendon-bone insertion
and the tendon belly, and increase the mechanical strength of
the regenerated tendon in a rabbit model [4]. In patients with ro-
tator cuff tendon tear, ultrasound andmagnetic resonance imag-
ing have similar accuracy in the diagnosis of rotator cuff tear [16].
In a previous study of ultrasound-guided platelet-rich plasma
(PRP) injection in patients with rotator cuff disease, the authors
precisely localized the rotator cuff lesion using ultrasound and
successfully performed the PRP injection [3]. In this study, we in-
vestigated the therapeutic effects of ultrasound-guided human
UCB-derivedMSC injection to regenerate a full-thickness subsca-
pularis tendon tear in a rabbit model. We evaluated the gross
morphology and histology of the injected tendon and motion
analysis was used to assess improvement in functional ability
of the rabbit’s activity.
MATERIALS AND METHODS
Animal Model
Twelve-week-old male New Zealand white rabbits (n = 30) were
housed in separatemetal cagesat23°C62°Canda relativehumidity
of45°C610%.Theyhadfreeaccesstotapwaterandwerefedacom-
mercial rabbit diet. None of the rabbits received additional exercise;
theywere allowed todonormal activities in a 65345330 cmcage.
Animalexperimentswereperformedinaccordancewith internation-
ally accredited guidelines and approved by the Catholic University of
Daegu School of Medicine Animal Care and Use Committee.
Anesthesiawas induced using isoflurane (JWPharmaceutical,
Goyang, Korea, http://www.cwp.co.kr/pharma/en/intro/pharma.
jsp) vaporized in oxygen and delivered via a large animal cycling
system. Under general anesthesia, a 5-mm diameter, full-
thickness rotator cuff tear on the insertion site of left subscapu-
laris tendon was created by punch biopsy excision using a 5-mm
biopsy punch (SFM Medical Devices, Wa¨chtersbach, Germany,
http://sfm.de) (Fig. 1A). After the excision was made, the wound
was immediately closedby subcutaneous and skin sutures. The30
rabbits were randomly allocated into 3 different treatment
groups with 10 rabbits in each group. After the site of the
full-thickness subscapularis tendon tear was confirmed via
ultrasound, group 1 was injected with 0.1 ml of human UCB-
derived MSCs (Cartistem; Medipost Co. Ltd., Seoul, Korea,
http://www.medi-post.com), group 2 was injected with 0.1 ml
of hyaluronic acid (Hyruan-plus; LG Life Science, Daejeon, Korea,
www.lgls.com), and group 3 was injected with 0.1 ml of normal
saline (Fig. 2). All injections were performed under ultrasound
guidance by a physiatrist with a commercially available ultra-
sound system with a 3–12MHz multifrequency linear transducer
(E-CUBE15; AlpinionMedical Systems, Seoul, Korea, http://www.
alpinion.com) (Fig. 3B, 3C). No medication was administered and
all rabbits underwent immobilization inequinusposition, usingan
elastic bandage, for 2 days after the injection.
Mesenchymal Stem Cell Preparation
UCBwas collected from the umbilical vein after neonatal delivery
with informed consent from pregnant mothers, and MSCs were
isolated and cultivated from human UCB [2, 17]. The cells
expressed CD105 PE (99.6%), CD90 PE (99.3%), CD29 PE
(99.0%), CD166 PE (97.7%), CD73 PE (96.3%), CD45 fluorescein
isothiocyanate (FITC) (0.2%), CD14 FITC (0.1%), and human leuko-
cyte antigen (HLA)-DR FITC (0.1%) (Fig. 1B, 1C). The cells also
expressed pluripotent markers such as octamer-binding tran-
scription factor 4 (30.5%) and stage-specific embryonic antigen
4 (SSEA-4; 67.7%). Human UCB-derived MSCs differentiated into
various cell types, such as respiratory epithelium, osteoblasts,
chondrocytes, and adipocytes, with specific in vitro induction
stimuli (Fig. 1C) [13, 14, 18].We confirmed the differentiation po-
tential and karyotypic stability of the human UCB-derived MSCs
up to the 11th passage. The human UCB-derived MSCs were
mixed with viscous hyaluronic acid (HA) (Fig. 3A)
Gross Morphology and Histological Examination
Gross morphologic examinations were conducted at prior injec-
tion and when all 30 rabbits were euthanized 4 weeks postinjec-
tion. The severity of the tendon tear was classified as a partial- or
full-thickness tear. The surface area of subscapularis tendon tear
was photographedwith a clear plastic ruler near the center of the
tear site and its size was calculated using image J software (Na-
tional Institutes of Health, Bethesda, Maryland, http://imagej.
nih.gov/ij) by tracing the outlined tear edge at 4 weeks postinjec-
tion (Fig. 4A–4C). The tendon’s injection site was removed and
fixed with 10% neutral buffered formalin. Standard frontal sec-
tions of 4 mm were prepared and stained with hematoxylin and
eosin, Masson’s trichrome, and immunohistochemical staining
of type I collagen. Histological changes were analyzed by light
microscopy.
Immunohistochemical studies were conducted using mouse
anti-collagen 1 monoclonal antibody (Abcam, Cambridge, U.K.,
http://www.abcam.com). The paraffin-embedded sections among
three groups were cleared, dehydrated, and washed with
phosphate-buffered saline (PBS). Endogenous peroxidases were
inhibited by preincubation in 0.3% hydrogen peroxide in PBS
for 30 minutes, and nonspecific protein binding was blocked in
PBS containing 10%normal goat serum (Vector Laboratories, Bur-
lingame, CA, http://vectorlabs.com) for 30 minutes. The sections
were incubated in primary antibodies (1:50) for 3 hours at room
temperature and washed three times with PBS. The secondary
antibody (1:100), biotinylated anti-mouse immunoglobulin G
(Vector Laboratories) was placed on the sections for 1 hour at
room temperature and washed 3 times with PBS. Then,
avidin-biotin-peroxidase complex (Vector Laboratories) was
placed on the sections for 1 hour and washed 3 times with
PBS, followed by a peroxidase reaction using 0.05 mol/l Tris hy-
drochloride (pH 7.6) containing 0.01% hydrogen peroxide and
0.05% 3,39-diaminobenzidine (Sigma Aldrich, St. Louis, MO,
https://www.sigmaaldrich.com). The sections were counter-
stained with hematoxylin and then mounted.
The slides were investigated with the Axiophot photomicro-
scope (Carl Zeiss, Jena, Germany, http://www.zeiss.com) and Axi-
oCamMRc5 (Carl Zeiss). Each slide was evaluated according to the
intensityofpositive immunostaining,whichwasgradedas2, +, ++,
or +++, denoting negative, slightly positive, moderately positive,
and strongly positive staining, respectively [19]. We tested
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the fate of the human UCB-derived MSCs. We used a HLA ABC
stain to track human UCB-derived MSCs.
Motion Analysis
Motion analysis of the rabbits was conducted at preinjection and
4weeks postinjection. Rabbits were habituated for 30minutes to
the open field before motion analysis was performed. They were
placed on a 33 3 m arena and allowed to freely explore the field
for 5 minutes. Their movements were individually assessed using
a video-tracking system equipped with a camera (Smart; Panlab,
Barcelona, Spain, http://www.panlab.com) that records the rab-
bit’s horizontal activity. We measured walking distance, fast-
walking time, and mean walking speed for 5 minutes.
Statistical Analyses
Statistical analyses were performed using the SPSS V. 19.0 soft-
ware (IBM Corp., Armonk, NY, http://www-01.ibm.com). The
Kruskal-Wallis test was used to compare the sizes of the subsca-
pularis tendon tear and motion analysis data among the three
groups. TheWilcoxon signed-rank test was used to assess the dif-
ferences in motion analysis data pre- and postinjection within
each group. A p value less than .05 was considered statistically
significant.
RESULTS
At4weeks postinjection, apartial-thickness subscapularis tendon
tear was observed in 7 rabbits (70%) and full-thickness tendon
tear in 3 rabbits (30%) in group 1. In groups 2 and 3, a full-
thickness tendon tear was observed in all 10 rabbits.
The mean tendon tear size of groups 1, 2, and 3 at 4 weeks
postinjection was 2.94 6 0.18 mm2, 12.95 6 0.52 mm2, and
14.336 0.33mm2, respectively. Inall threegroups, the tendontear
sizes at postinjectionwere decreased comparedwith those at prein-
jection.Themeantendontear size ingroup1wassignificantly smaller
than those in groups 2 and 3 (p , .05) (Fig. 4D–4F). There was no
significant difference of tendon tear size between groups 2 and 3.
By hematoxylin and eosin staining, parallel arrangement of
hypercellular fibroblastic bundles was observed in group 1 (Fig.
4G) but not in groups 2 and 3 (Fig. 4H, 4I). As seen with Masson’s
trichrome staining, regenerated collagen fibers were connected
to adjacent muscle fibers and stained with anti-type 1 collagen
antibody in group 1 (Fig. 5A–5C). The intensity of positive type
I collagen immunostaining in group 1 was classified as follows:
moderate expression in 4, slight in 3, and negative in 3 rabbits
at 4 weeks postinjection. Negative expression was found in all
10 rabbits of groups 2 and 3 (Table 1). The analysis of cell rejection
was performed in the group of rabbits in which cells were
implanted. The microscopic assessment of the tissue around
Figure 1. Creation of the rotator cuff tear andmesenchymal stem cell (MSC) differentiation. (A): Three panels show the techniques and equip-
ment required to create a 5-mm diameter full-thickness rotator cuff tear by punch biopsy excision. (B): Characterization of flow cytometry. (C):
Differentiation data of the MSCs. Osteo: 2 weeks, alkaline phosphatase; magnification, 3200. Chondro: 4 weeks, Safranin O; magnification,
3200.Adipo: 4weeks,Oil RedO;magnification,3200.Abbreviations: adipo, adipocyte; chondro, chondrycyte; FITC, fluorescein isothiocyanate;
HLA, human leukocyte antigen; osteo, osteocyte.
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the implanted cells revealed no evidence of immune rejection,
such as vasculitis and lymphocyte infiltration. Therefore, we
foundnoevidenceof cell rejection reaction in the specimens from
the implanted-cells group. The cell tracking experiment with the
HLA ABC stain showed that human UCB-derivedMSCs injected at
the tendon tear siteweredetected in the implanted-cells groupat
4 weeks after injection.
There was no significant difference in the walking distance,
the fast-walking time, and the mean walking speed among the
three groups at preinjection. The mean walking distances in
groups 1, 2, and 3 at 4 weeks postinjection were 7,088.65 6
2,202.08 cm, 4,149.79 6 985.75 cm, and 4,255.01 6 955.09 cm,
respectively. The mean fast-walking times for groups 1, 2,
and 3 were 12.57% 6 7.04%, 5.70% 6 1.55% and 5.51% 6
1.55%, respectively. The mean walking speeds for groups 1, 2,
and 3 were 10.82 6 4.38 cm/second, 5.89 6 1.26 cm/second,
and 5.886 1.32 cm/second, respectively (Fig. 6A–6C). The mean
walking distances at 4 weeks postinjection in all 3 groups were
Figure 3. Humanumbilical cord blood-derivedmesenchymal stem cell (MSC) and ultrasound images. (A):Humanumbilical cord blood-derived
MSCs. (B): Injection was made in the left shoulder subscapularis (SCC) full-thickness tears under ultrasound guidance. (C): Longitudinal ultra-
sound image showed the needle (arrows) in the left shoulder SCC of the rabbit. Abbreviations: S, mesenchymal stem cell; T, tendon.
Figure2. Time lineof saline,HA, andMSC injection.MSCs (0.1ml; group1),HA (0.1ml; group2), and saline (0.1ml; group3)were injectedunder
ultrasound guidance into the left shoulder subscapularis full-thickness tears immediately after the tears were created. Themotion analysis was
performed before the creation of tendon tear and 4 weeks after injection of 3 different solutions. All rabbits were euthanized by carbon mon-
oxide inhalation at 4weeks after injection of 3 different solutions. Abbreviations: HA, hyaluronic acid,MSC, human umbilical cord blood-derived
mesenchymal stem cell.
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significantly longer than those at preinjection. In group1, the fast-
walking timeandmeanwalking speedatpostinjectionwere faster
andhigher thanat preinjection.However, therewasno significant
difference in the fast-walking time and the mean walking speed
between preinjection and postinjection in groups 2 and 3. The
walking distance, fast-walking time, and mean walking speed at
4weeks postinjectionwere significantly longer, faster, and higher
in group 1 comparedwith those in groups 2 and 3 (Fig. 6A–6C). No
adverse effects were observed after the injections.
DISCUSSION
At 4 weeks after ultrasound-guided, UCB-derivedMSC injection, 7
of the 10 full-thickness subscapularis tendon tears were only
partial-thickness tears and 3 remained full-thickness tendon tears.
However, the full-thickness tendon tear was unchanged in all 10
rabbits after HA and normal saline injection. The 5-mm-diameter
tendon tear size before injection decreased after 3 kinds of injec-
tions, but the tendon tear size afterMSC injectionwas significantly
smaller than those after HA and normal saline injection.
Histological analysis revealed that the regenerated tissues
were predominantly composed of type I collagen, which is the
main component of extracellular matrices in tendons that con-
nect to adjacentmuscle fibers.Motion analysis revealed the loco-
motor function of rabbits after UCB-derived MSC injection was
better comparedwith rabbits injectedwith HA and normal saline.
This is the first report to demonstrate that ultrasound-guided, hu-
man UCB-derived MSC injection can induce regeneration of the
full-thickness rotator cuff tendon tear and functional improve-
ment without surgical repair in rabbit models.
Rotator cuff tendon tear is a common cause of shoulder pain
and morbidity. Previous studies have shown that a surgically
repaired rotator cuff tendon has a persistent defect at the repair
site in 11%–94%of cases [20, 21]. Poor blood supply, intrinsic ten-
don degeneration, muscle atrophy, and fatty infiltration can con-
tribute to tendon failure after surgical repair. Therefore, new
biological treatments such as growth factors and cytokines, gene
therapy, and tissue engineering with stem cells are required to
enhance tendon healing [22]. Although the efficacy of these bio-
logical agents has yet to be proven, they are promising andmight
increase the chances for a successful outcome in treatment of
tendon pathology. A recent animal study has demonstrated that
growth factors and cytokines might have regenerative effects in
rotator cuff tendon healing [23]. However, further studies are
necessary to delineate the best method for their use in terms
of time, administration method, and dosage.
The main cause for tendon failure after surgical repair is im-
mature fibrovascular scar formation that contains a high amount
of type III collagens. Type III collagen is mechanically weaker than
type I collagen, the main component of extracellular matrices in
tendons [24, 25]. In the maturation and remodeling stage of the
tendon healing process, which is characterized by scar tissuemat-
uration, the immature type III collagen is replaced by type I colla-
gen with the formation of dense connective tissue. In our study,
the hypercellular fibroblastic bundles composed of type I colla-
gens were observed in the regenerated tendon at 4 weeks after
human UCB-derived MSC injection. This means that the MSC in-
jection promoted the normal tendon healing process in the repair
of full-thickness tendon tears.
Our study revealed that humanUCB-derivedMSCs injected at
the tendon tear siteweredetected in the implanted-cells groupat
4 weeks after injection. The precise mechanism by which UCB-
derived MSCs enhance the tendon regeneration is unclear. It is
suggested that tendon regeneration might be attributable to
the one of two roles of MSCs. MSCs may work through either dif-
ferentiation into cells capable of synthesizing tendonmatrix or se-
cretion of factors that induce adjacent cells to synthesize tendon
matrix [26, 27]. The study by Kryger et al. [28] reported thatMSCs
survived well on decellularized tendon matrices, and that equine
MSCs, cultured on fresh acellular equine tendon sections, not
only survived, proliferated, and invaded thematrix but also upre-
gulated the glycoprotein cartilage oligomericmatrix protein gene
Figure4. Grossmorphological (A–F) andhistological (G–I) findings of the subscapularis tendons in groups 1, 2, and3. Thepolygon in eachof the
first six images depicts the area of the full-thickness subscapularis tendon tear. (A–C): Pretreatment images. (D–F): Posttreatment images. (G):
Parallel arrangement of hypercellular fibroblastic bundles (arrow) was noted in group 1. (H, I): Histological findings in groups 2 and 3 showed
absence of fiber bundles. Group 1 received a 0.1-ml injection of MSCs; group 2, 0.1 ml of HA; group 3, 0.1 ml of saline. Hematoxylin-and-eosin
stain,340. Abbreviations: MSC, human umbilical cord blood-derived mesenchymal stem cell; HA, hyaluronic acid; SSC, subscapularis muscle.
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expression,whichhas a restricteddistribution in tendonprimarily
designed to withstand load. In addition, the other in vitro study
showed that long-term contact with MSCs for 3 weeks changed
the morphology of implanted cells and resulted in many similar-
ities between tenocytes andMSCs lined up with the collagen fas-
cicles [29]. Therefore, we suggest that even a small number of
survivingMSCs can have the therapeutic effects of tendon regen-
eration primarily through direct tissue repair rather than secre-
tion of key bioactive mediators.
After MSC injection, 7 of the 10 full-thickness subscapularis
tendon tears turned into partial-thickness tears, but 3 full-
thickness tendon tears remained unchanged. This partial regener-
ation might be caused by an insufficient therapeutic effect due to
low injection volume of UCB-derived MSCs, short-term follow-up
period, large tear size, or short-term immobilizationafter injection.
In our study, human UCB-derived MSCs were used for ten-
don repair in rabbits. UCB-derived MSCs are known to be less
immunogenic because they have low expression levels of HLA-
major histocompatibility complex (MHC) class I and lack of MHC
class II molecules that induce the immune evasion in the allo-
genic transplantation [30]. In addition, the recent study using
human umbilical cord blood-derived mesenchymal stem cells
in anterior cruciate ligament reconstruction of a rabbit model
showed that no evidence of immune rejection [31]. This finding
is in accordance with our finding.
We performed the motion analysis of rabbits instead of the
mechanical properties of a regenerated tendon after the injec-
tion.Motion analysis assesses the activity of rabbits to determine
whetherUCB-derivedMSC injectionhadabetter functional effect
on the healing of full-thickness rotator cuff tendon tears com-
pared with HA or normal saline injection. The walking distance,
fast-walking time, and the mean walking speed in the UCB-
derived MSC injection group were significantly farther, faster,
and greater than those in HA and normal saline injection groups
at 4 weeks postinjection. These results suggest that the regener-
ated rotator cuff tendon function in walking ability was improved
after UCB-derived MSC injection than HA and normal saline
injections.
In our study, the full-thickness subscapularis tendon tear in
rabbits was used. The subscapularis tendon tear in rabbits is com-
monly used as a model to study rotator cuff tendon regenera-
tion, since the subscapularis tendon in rabbits is similar to the
supraspinatus tendon in humans [4, 32].
Since the normal tendon healing process after injury is slow
and leads to fibrotic scarring and adhesion, it is not functionally
sufficient to repair the injured tendon tissue. This limitation
has triggered an intense investigation into cell-mediated tendon
Table 1. Immunoreactivity of type I collagen according to treatment
groups at 4 weeks after injection
Intensity of positive
type I collagen
immunostaining
Group 1a
(n = 10), no.
Group 2a
(n = 10), no.
Group 3a
(n = 10), no.
++ 4 0 0
+ 3 0 0
2 3 10 10
aTreatment doses: group 1, 0.1ml ofMSCs; group 2, 0.1ml of hyaluronic
acid; group 3, 0.1 ml of saline.
Abbreviations:2, negative; +, slightly positive; ++, moderately positive.
Figure 5. Histological micrographs of tissue from group 1 rabbits. (A): Newly regenerated tendons are shown in the blue-stained fibers (black
arrow; Masson’s trichrome stain; magnification, 312.5). (B): Regenerated tendon fibers (yellow arrowhead; Masson’s trichrome stain; mag-
nification, 3250) are connected to adjacent M fibers. (C): The regenerated tendon fibers (black arrow) stained with anti-type 1 collagen an-
tibody. The defect was reconstructed with human umbilical cord blood-derived mesenchymal stem cells (magnification,3100). Abbreviation:
M, muscle.
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therapies, given the low activity/low cell numbers of tendons. In
cell-mediated treatment, a cell suspension can be injected at the
site of lesion without surgical repairs. There is a report regarding
successful results using platelet-rich plasma or stem cell injection
without surgical repair in lateral epicondylitis [33]. The effect of
cell-mediated treatment combined with surgical repair has been
reported mostly in rotator cuff tears. In studies of stem cell ther-
apy with surgical repair, stem cell injection is only an adjuvant
therapy, and the effect of surgical repair overshadows the exact
role of stem cell injection for the regeneration of the injured ten-
don. Our previous study [34] reported that ultrasound-guided
platelet-rich plasma injection in rotator cuff diseasehadapositive
therapeutic effect on healing of the rotator cuff tendon. There-
fore,we thought stemcell injectionhasmore regenerative poten-
tial for rotator cuff tendon tears than platelet-rich plasma
injection. This is the first study to demonstrate the therapeutic
effects of ultrasound-guided, human UCB-derived MSC injection
to regenerate a full-thickness subscapularis tendon tear without
surgical repair in a rabbit model.
There are some limitations in our study. First, we made an
acute, full-thickness rotator cuff tendon tear using punch biopsy
excision to resemble an acute traumatic tear. Therefore, it did not
reflect chronic degenerative rotator cuff tendon tear in humans.
Second, the partial-thickness and various sized full-thickness ten-
don tears were not used for the tendon regeneration. Third, the
rabbits underwent immobilization for 2 days after the injection.
Postoperative immobilization using a sling after the surgical re-
pair of the rotator cuff is recommended for the first 4–6 weeks
postoperatively to reduce stress on the operated tendon and im-
provemicrocirculation [35]. It is uncertain that 2 days of immobi-
lization after injectionwas sufficient to heal the tendon tear in the
rabbit model. Fourth, rehabilitative treatment after the injection
wasnotperformed. The rehabilitative treatmentprotects the sur-
gical repair in the early stages of the tendon healing process and
restores the function of the shoulder joint [36]. Fifth, we did not
perform the biomechanical test of the regenerative tendon.
Therefore, future studies need to address the biomechan-
ical property of the injected tendon, the long-term effects of
UCB-derived MSCs, differences in various full-thickness tendon
tear size, the appropriate immobilization period after injection,
the optimal dose of UCB-derivedMSCs, comparison with surgical
repair, the most effective rehabilitation protocol after injection,
and human trials.
CONCLUSION
UCB-derived MSC injection under ultrasound guidance without
surgical repair or bioscaffold resulted in the partial healing of
full-thickness rotator cuff tendon tears in a rabbit model. Histol-
ogy revealed that UCB-derivedMSCs induced regeneration of ro-
tator cuff tendon tears and that the regenerated tissue was
predominantly composed of type I collagens. In addition, motion
analysis showed better walking capacity after MSC injection
than HA or normal saline injection. These results suggest that
ultrasound-guided UCB-derived MSC injection may be a useful
conservative treatment for full-thickness rotator cuff tendon tear
repair.
ACKNOWLEDGMENTS
This study was supported by a Korea of Health & Welfare grant,
Republic of Korea (Projects 090-091-3000-3033-320and090-091-
3000-3033-340-320-01). We thank professor and anatomist
Yong-SukMoon for collecting and analyzing histological data pre-
sented in this article.
AUTHOR CONTRIBUTIONS
G.-Y.P. and S.C.L.: conception and design, financial support, man-
uscript writing, final approval of manuscript; D.R.K.: conception
and design, provision of study material, data analysis and inter-
pretation, manuscript writing, final approval of manuscript.
DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
The authors indicated no potential conflicts of interest.
REFERENCES
1 Aslam M, Baveja R, Liang OD et al. Bone
marrow stromal cells attenuate lung injury in
a murine model of neonatal chronic lung dis-
ease. Am J Respir Crit Care Med 2009;180:
1122–1130.
2 Baydar M, Akalin E, El O et al. The efficacy
of conservative treatment in patients with full-
thickness rotator cuff tears. Rheumatol Int
2009;29:623–628.
3 BergerMJ, Adams SD, Tigges BMet al. Dif-
ferentiation of umbilical cord blood-derived
multilineage progenitor cells into respiratory
epithelial cells. Cytotherapy 2006;8:480–487.
4 Boiani M, Scho¨ler HR. Regulatory net-
works in embryo-derived pluripotent stem cells.
Nat Rev Mol Cell Biol 2005;6:872–884.
5 Castricini R, Longo UG, De Benedetto M
et al. Platelet-rich plasma augmentation for ar-
throscopic rotator cuff repair: a randomized
controlled trial. Am J Sports Med 2011;39:
258–265.
6 Chang YS, Choi SJ, Sung DK et al. Intratra-
cheal transplantation of human umbilical cord
blood-derived mesenchymal stem cells dose-
dependently attenuates hyperoxia-induced
Figure 6. Graphs comparing walking distance (A), fast-walking time (B), and mean walking speed (C) among three groups. p, p, .05 by Wil-
coxon signed-rank test; †, p, .05 by Kruskal-Wallis test among 3 groups. Gray bars, preinjection; black bars, 4 weeks postinjection. Abbrevia-
tions: HA, hyaluronic acid; MSC, human umbilical cord blood-derived mesenchymal stem cell.
1350 Tendon Regeneration Using Cord Blood Stem Cells
©AlphaMed Press 2015 STEM CELLS TRANSLATIONAL MEDICINE
lung injury in neonatal rats. Cell Transplant
2011;20:1843–1854.
7 Chang YS, Oh W, Choi SJ et al. Human um-
bilical cord blood-derived mesenchymal stem
cells attenuate hyperoxia-induced lung injury in
neonatal rats. Cell Transplant 2009;18:869–886.
8 Cheung EV, Silverio L, Sperling JW. Strate-
gies in biologic augmentation of rotator cuff re-
pair: A review. Clin Orthop Relat Res 2010;468:
1476–1484.
9 Cofield RH, Parvizi J, Hoffmeyer PJ et al.
Surgical repair of chronic rotator cuff tears. A
prospective long-term study. J Bone Joint Surg
Am 2001;83-A:71–77.
10 Edwards SL, Lynch TS, SaltzmanMD et al.
Biologic and pharmacologic augmentation of
rotator cuff repairs. J Am Acad Orthop Surg
2011;19:583–589.
11 Galatz LM, Ball CM, Teefey SA et al. The
outcome and repair integrity of completely
arthroscopically repaired large and massive ro-
tator cuff tears. J Bone Joint SurgAm2004;86-A:
219–224.
12 Gang EJ, Bosnakovski D, Figueiredo CA
et al. SSEA-4 identifies mesenchymal stem cells
frombonemarrow.Blood2007;109:1743–1751.
13 Gerber C, Fuchs B, Hodler J. The results of
repair of massive tears of the rotator cuff. J
Bone Joint Surg Am 2000;82:505–515.
14 Grumet RC, Hadley S, Diltz MV et al. De-
velopment of a new model for rotator cuff pa-
thology: The rabbit subscapularis muscle. Acta
Orthop 2009;80:97–103.
15 Awad HA, Boivin GP, Dressler MR et al.
Repair of patellar tendon injuries using a cell-
collagen composite. J Orthop Res 2003;21:
420–431.
16 Hayatsu K, De Deyne PG.Muscle adapta-
tion during distraction osteogenesis in skele-
tally immature and mature rabbits. J Orthop
Res 2001;19:897–905.
17 Isaac C,GharaibehB,WittMetal. Biologic
approaches to enhance rotator cuff healing after
injury. J Shoulder Elbow Surg 2012;21:181–190.
18 Lafosse L, Brozska R, Toussaint B et al.
The outcome and structural integrity of arthro-
scopic rotator cuff repairwithuseof thedouble-
row suture anchor technique. J Bone Joint Surg
Am 2007;89:1533–1541.
19 Sohn DS, Moon JW, Lee WH et al. Com-
parison of new bone formation in the maxillary
sinus with and without bone grafts: immuno-
chemical rabbit study. Int J Oral Maxillofac
Implants 2011;26:1033–1042.
20 LeBlancK. Immunomodulatoryeffects of
fetal and adult mesenchymal stem cells. Cyto-
therapy 2003;5:485–489.
21 Lee JK, LeeMK, Jin HJ et al. Efficient intra-
cytoplasmic labeling of human umbilical cord
blood mesenchymal stromal cells with ferum-
oxides. Cell Transplant 2007;16:849–857.
22 Longo UG, Lamberti A, Maffulli N et al.
Tissue engineered biological augmentation for
tendon healing: A systematic review. Br Med
Bull 2011;98:31–59.
23 Longo UG, Rizzello G, Berton A et al. Bio-
logical strategies to enhance rotator cuff heal-
ing. Curr Stem Cell Res Ther 2013;8:464–470.
24 Pittenger MF, Mackay AM, Beck SC et al.
Multilineage potential of adult human mesen-
chymal stem cells. Science 1999;284:143–147.
25 Rocha V, Wagner JE Jr., Sobocinski KA
et al. Graft-versus-host disease in children
who have received a cord-blood or bone mar-
row transplant from an HLA-identical sibling.
N Engl J Med 2000;342:1846–1854.
26 Murphy JM, Fink DJ, Hunziker EB et al.
Stem cell therapy in a caprinemodel of osteoar-
thritis. Arthritis Rheum 2003;48:3464–3474.
27 Caplan AI, Dennis JE. Mesenchymal stem
cells as trophic mediators. J Cell Biochem 2006;
98:1076–1084.
28 Kryger GS, Chong AK, Costa M et al. A
comparison of tenocytes and mesenchymal
stem cells for use in flexor tendon tissue engi-
neering. J Hand Surg Am 2007;32:597–605.
29 Ouyang HW, Goh JC, Lee EH. Viability of
allogeneic bonemarrow stromal cells following
local delivery into patella tendon in rabbit
model. Cell Transplant 2004;13:649–657.
30 Tempelhof S, Rupp S, Seil R. Age-related
prevalence of rotator cuff tears in asymptom-
atic shoulders. J Shoulder Elbow Surg 1999;8:
296–299.
31 Jang KM, Lim HC, Jung WY et al. Efficacy
and safety of human umbilical cord blood-
derivedmesenchymal stemcells in anterior cru-
ciate ligament reconstructionof a rabbitmodel:
new strategy to enhance tendon graft healing.
Arthroscopy 2015;31:1530–1539.
32 Yang SE, Ha CW, JungM et al. Mesenchy-
mal stem/progenitor cells developed in cultures
from UC blood. Cytotherapy 2004;6:476–486.
33 Connell D, Datir A, Alyas F et al. Treat-
ment of lateral epicondylitis using skin-derived
tenocyte-like cells. Br J Sports Med 2009;43:
293–298.
34 Rha DW, Park GY, Kim YK et al. Compar-
ison of the therapeutic effects of ultrasound-
guided platelet-rich plasma injection and dry
needling in rotator cuff disease: A random-
ized controlled trial. Clin Rehabil 2013;27:
113–122.
35 Yokoya S, Mochizuki Y, Nagata Y et al.
Tendon-bone insertion repair and regeneration
using polyglycolic acid sheet in the rabbit rota-
tor cuff injurymodel. Am J SportsMed 2008;36:
1298–1309.
36 Yokoya S, Mochizuki Y, Natsu K et al. Ro-
tator cuff regeneration using a bioabsorbable
material with bonemarrow-derivedmesenchy-
mal stem cells in a rabbit model. Am J Sports
Med 2012;40:1259–1268.
Park, Kwon, Lee 1351
www.StemCellsTM.com ©AlphaMed Press 2015
